Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy

Acta Neuropathologica Communications
Laura J BlairChad A Dickey

Abstract

The blood-brain barrier (BBB) is damaged in tauopathies, including progressive supranuclear palsy (PSP) and Alzheimer's disease (AD), which is thought to contribute to pathogenesis later in the disease course. In AD, BBB dysfunction has been associated with amyloid beta (Aß) pathology, but the role of tau in this process is not well characterized. Since increased BBB permeability is found in tauopathies without Aß pathology, like PSP, we suspected that tau accumulation alone could not only be sufficient, but even more important than Aß for BBB damage. Longitudinal evaluation of brain tissue from the tetracycline-regulatable rTg4510 tau transgenic mouse model showed progressive IgG, T cell and red blood cell infiltration. The Evans blue (EB) dye that is excluded from the brain when the BBB is intact also permeated the brains of rTg4510 mice following peripheral administration, indicative of a bonafide BBB defect, but this was only evident later in life. Thus, despite the marked brain atrophy and inflammation that occurs earlier in this model, BBB integrity is maintained. Interestingly, BBB dysfunction emerged at the same time that perivascular tau emerged around major hippocampal blood vessels. However, when tau expression was s...Continue Reading

References

Jan 1, 1988·Neurobiology of Aging·A D Mooradian
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R D Broadwell, M Salcman
Apr 1, 1993·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·R Schmidt-KastnerU T Eysel
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·B GhettiF Tagliavini
Nov 7, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R S PiotrowiczE G Levin
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·H WenkelM J Young
Feb 6, 2002·The Journal of Clinical Investigation·Donnasue GraesserJoseph A Madri
Jun 12, 2002·The American Journal of Pathology·Mark S FormanJohn Q Trojanowski
Sep 10, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ernst SeiffertAlon Friedman
Dec 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anna A BirukovaAlexander D Verin
Feb 1, 2005·Annals of the New York Academy of Sciences·Patrick L McGeer, Edith G McGeer
Apr 9, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mark S FormanJohn Q Trojanowski
Jul 13, 2005·Neuropathology and Applied Neurobiology·S WilliamsS Love
Nov 18, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Martin RamsdenKaren H Ashe
Dec 24, 2005·Nature Reviews. Neuroscience·N Joan AbbottElisabeth Hansson
May 3, 2006·The American Journal of Pathology·Tara L SpiresBradley T Hyman
Apr 6, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zdenek BergerChristopher Janus
May 12, 2007·Brain Pathology·Dennis W DicksonMichael L Hutton
Jun 26, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gerty SchreibeltHelga E de Vries
Feb 15, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Donna M WilcockCarol A Colton
Nov 1, 2008·The European Journal of Neuroscience·Samuel TétraultFlorin Amzica
Dec 17, 2008·The American Journal of Pathology·Chad DickeyJada Lewis
Dec 24, 2008·The Journal of Clinical Investigation·Vanessa BrochardStéphane Hunot
May 19, 2009·Journal of Cellular and Molecular Medicine·John KorenChad A Dickey
Jun 9, 2009·Nature Cell Biology·Florence ClavagueraMarkus Tolnay
Sep 15, 2009·Journal of Alzheimer's Disease : JAD·Andrej KovacMichal Novak
Dec 18, 2009·The Journal of General Virology·Penny A RuddVeronika von Messling
Mar 9, 2010·CNS & Neurological Disorders Drug Targets·Shweta Mandrekar-Colucci, Gary E Landreth
Jul 20, 2010·American Journal of Physiology. Lung Cellular and Molecular Physiology·Bing ZhuTroy Stevens
Sep 18, 2010·Journal of Neuroinflammation·Daniel C LeeDave Morgan
Nov 19, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jose F AbisambraChad A Dickey

❮ Previous
Next ❯

Citations

Oct 31, 2015·Neurodegenerative Disease Management·Isabelle St-AmourFrancesca Cicchetti
Sep 12, 2015·Human Molecular Genetics·J Nicholas CochranErik D Roberson
May 22, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cláudia SaraivaLiliana Bernardino
Jul 19, 2016·Neurobiology of Disease·Elena ZenaroGabriela Constantin
Oct 26, 2016·Brain Research Bulletin·Thomas ArendtMax Holzer
Sep 24, 2016·Journal of Alzheimer's Disease : JAD·William A BanksJing Zhang
Nov 5, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tengfei LiPierre Lafaye
Mar 18, 2017·Frontiers in Immunology·Enrica Caterina PietronigroGabriela Constantin
Aug 3, 2017·Molecular Brain·Juhyun SongByeong C Kim
Apr 28, 2018·Journal of Neural Transmission·Petra MajerovaAndrej Kovac
Oct 25, 2017·The Journal of Experimental Medicine·Axel MontagneBerislav V Zlokovic
Oct 4, 2018·Physiological Reviews·Melanie D SweeneyBerislav V Zlokovic
Jun 6, 2017·Aging and Disease·Diana L Castillo-CarranzaRakez Kayed
Feb 8, 2018·Acta Neuropathologica·Stefan LiebnerGabriela Constantin
May 6, 2019·The Journal of Biological Chemistry·Aleksandra P PiteraKatrin Deinhardt
Jul 7, 2019·Acta Neuropathologica Communications·Thomas VogelsTomáš Hromádka
Nov 26, 2015·Journal of Alzheimer's Disease : JAD·Erica M Weekman, Donna M Wilcock
Dec 5, 2019·Current Topics in Medicinal Chemistry·Jiayang XieBing Niu
Mar 3, 2020·Nutritional Neuroscience·P A Pérez-CorredorG P Cardona-Gómez
Feb 1, 2020·Neurology·Elisa de Paula França ResendeLea T Grinberg
Jul 14, 2020·Hypertension·Monica M SantistebanCostantino Iadecola
Aug 23, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Chia-Chen LiuGuojun Bu
Sep 27, 2018·Nature Neuroscience·Melanie D SweeneyBerislav V Zlokovic
Feb 14, 2020·Brain Communications·Alexandra J WeigandUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Aug 20, 2020·Acta Neuropathologica Communications·Rachel E BennettBradley T Hyman
Aug 12, 2020·Nature Neuroscience·Marc Aurel Busche, Bradley T Hyman
Apr 17, 2019·International Journal of Molecular Sciences·Michelle A Erickson, William A Banks
Sep 22, 2017·Alzheimer's Research & Therapy·Thomas BlackmoreFrancois Gastambide
Dec 21, 2017·Brain Structure & Function·Yann DeckerKlaus Fassbender
Dec 19, 2019·International Journal of Molecular Sciences·Pablo CisternasCristian A Lasagna-Reeves
Jan 13, 2019·British Journal of Pharmacology·Jessica S Sadick, Shane A Liddelow
Feb 28, 2019·Acta Neuropathologica Communications·Yingjian YouCristian A Lasagna-Reeves
Jan 16, 2019·Nature Medicine·Daniel A NationBerislav V Zlokovic

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
chip

Software Mentioned

ImageJ
NearCYTE

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.